Morel Rubinger

1.7k citations
43 papers · 1.4k · 1 hit paper · h-index 18

Impact in

  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
    • Hemophilia Treatment and Research
    • Lymphoma Diagnosis and Treatment

Papers in

    • Hematopoietic Stem Cell Transplantation 11
    • Hemophilia Treatment and Research 3
    • Acute Myeloid Leukemia Research 3
    • Multiple Myeloma Research and Treatments 3
    • Lymphoma Diagnosis and Treatment 11

Morel Rubinger

43 papers receiving 1.4k citations

Morel Rubinger's Hit Papers

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12 2014 · 383 citations
3830+4+8Years since publication100200300

Peers

Morel Rubinger
Comparison fields: 5 of 65
  • Hematology 465
  • Pathology and Forensic Medicine 482
  • Oncology 263
  • Biochemistry 24
  • Infectious Diseases 55
Replace R. Arranz with:
R. Arranz Spain
Burhan Ferhanoğlu Türkiye
Frank Sheng Fan Taiwan
Ho‐Young Yhim South Korea
Andreas K. Klein United States
Chao‐Hung Ho Taiwan
Sung‐Hyun Kim South Korea
Gerhard Ehninger Germany
Stéphane Girault France
Sung-Nam Lim South Korea
Morel Rubinger relative to R. Arranz Spain R. Arranz's profile →
Citations per field
00.5×1.5×
R. Arranz · 1×
Citations per year

Countries citing papers authored by Morel Rubinger

Since Specialization
Citations

This map shows the geographic impact of Morel Rubinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morel Rubinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morel Rubinger more than expected).

Fields of papers citing papers by Morel Rubinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morel Rubinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morel Rubinger. The network helps show where Morel Rubinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Morel Rubinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Morel Rubinger Line = papers co-authored together Morel Rubinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
Hit paper breakdown →
2014383
2 2013116
3 199786
4 199175
5 201375
6 200872
7 199163
8 201452
9 200250
10 199642
11 200835
12 199728
13 201127
14 199826
15 200124
16 201621
17 201320
18 199718
19
An epidemiological review of red cell transfusions in cancer chemotherapy.
199918
20 199516

About Morel Rubinger

Morel Rubinger is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Biochemistry and Parasitology, having authored 43 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Hematopoietic Stem Cell Transplantation (11 papers), Neutropenia and Cancer Infections (4 papers), Hemophilia Treatment and Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Blood transfusion and management (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Hematology (465 citations), Pathology and Forensic Medicine (482 citations), Oncology (263 citations), Biochemistry (24 citations) and Infectious Diseases (55 citations). Morel Rubinger has collaborated with scholars based in Canada, United States and Saudi Arabia. Frequent co-authors include Eric J. Bow, Tsiporah B. Shore, Brent Schacter, David Szwajcer, Mary Cheang, Matthew D. Seftel, Gaynor J. Williams, Christopher Bredeson, A Demers and Regan Guilfoyle. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, American Journal of Hematology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact